Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Non SARS-Cov-2 Kits > VEGFA > EP-141

VEGFA [Biotinylated] : VEGFR2 Inhibitor Screening ELISA Kit

For research use only.
IDComponentsSize
EP141-C01High-bind Plate1 plate
EP141-C02Human VEGF R250 μg
EP141-C03Biotinylated Human VEGFA10 μg
EP141-C04Anti-VEGF Neutralizing Antibody20 μg
EP141-C05Streptavidin-HRP10 μg
EP141-C06Coating Buffer12 mL
EP141-C0710xWashing Buffer 50 mL
EP141-C08Blocking Buffer50 mL
EP141-C09Substrate Solution24 mL
EP141-C10Stop Solution7 mL
  • Background
    Kinase insert domain receptor (KDR) is also known as CD309, FLK1, VEGFR, VEGFR2, and is one of the subtypes of VEGFR. VEGF receptors are receptors for vascular endothelial growth factor (VEGF). There are three main subtypes of VEGFR, numbered 1, 2 and 3. The VEGF receptors have an extracellular portion consisting of 7 immunoglobulin-like domains, a single transmembrane spanning region and an intracellular portion containing a split tyrosine-kinase domain. VEGF-A binds to VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1). VEGFR-2 appears to mediate almost all of the known cellular responses to VEGF.The function of VEGFR-1 is less well defined, although it is thought to modulate VEGFR-2 signaling. Another function of VEGFR-1 may be to act as a dummy/decoy receptor, sequestering VEGF from VEGFR-2 binding (this appears to be particularly important during vasculogenesis in the embryo). In addition, VEGFR2 is able to interact with HIV-1 extracellular Tat protein upon VEGF activation, and seems to enhance angiogenesis in Kaposis sarcoma lesions.
  • Application
    This kit is developed for screening for inhibitors of human VEGFA binding to human VEGFR2.

    It is for research use only.

  • Reconstitution
    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage
    The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
    This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new VEGF165 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human VEGF165 to immobilized human VEGF R2 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated VEGF165 protein, a human VEGF R2 protein, an anti-VEGF neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

    Your experiment will include 4 simple steps:

    a) Coat the plate with human VEGF R2.

    b) Add your molecule of interest to the tests.

    c) Add human VEGF165-Biotin to bind the coated VEGF R2.

    d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

    Finally, the half maximal inhibitory concentration (IC50) of your compound to VEGF165: VEGF R2 binding will be determined by comparing OD readings among different experimental groups.

Typical Data
 VEGFA ELISA

INHIBITION OF VEGFA[Biotinylated]: VEGF R2 BINDING BY ANTI-VEGFA NEUTRALIZING ANTIBODY
Serial dilutions of Anti-VEGFA Neutralizing antibody (Catalog # EP141-C04) (1:1 serial dilution, from 20 μg/mL to 0.01μg/mL) was added into Biotinylated VEGFA: VEGF R2 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

Comments (0)


ETD of in-stock products: 2 business days

Price(USD) : $650.00

Promotion & Exhibitions



Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message